1. Home
  2. SBSI vs WGSWW Comparison

SBSI vs WGSWW Comparison

Compare SBSI & WGSWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBSI
  • WGSWW
  • Stock Information
  • Founded
  • SBSI 1960
  • WGSWW 2017
  • Country
  • SBSI United States
  • WGSWW United States
  • Employees
  • SBSI N/A
  • WGSWW N/A
  • Industry
  • SBSI Major Banks
  • WGSWW Retail: Computer Software & Peripheral Equipment
  • Sector
  • SBSI Finance
  • WGSWW Technology
  • Exchange
  • SBSI Nasdaq
  • WGSWW Nasdaq
  • Market Cap
  • SBSI N/A
  • WGSWW N/A
  • IPO Year
  • SBSI N/A
  • WGSWW N/A
  • Fundamental
  • Price
  • SBSI $30.34
  • WGSWW $0.25
  • Analyst Decision
  • SBSI Hold
  • WGSWW
  • Analyst Count
  • SBSI 2
  • WGSWW 0
  • Target Price
  • SBSI $37.00
  • WGSWW N/A
  • AVG Volume (30 Days)
  • SBSI 99.4K
  • WGSWW 35.4K
  • Earning Date
  • SBSI 01-29-2025
  • WGSWW 02-18-2025
  • Dividend Yield
  • SBSI 4.75%
  • WGSWW N/A
  • EPS Growth
  • SBSI N/A
  • WGSWW N/A
  • EPS
  • SBSI 2.91
  • WGSWW N/A
  • Revenue
  • SBSI $254,514,000.00
  • WGSWW $305,450,000.00
  • Revenue This Year
  • SBSI N/A
  • WGSWW N/A
  • Revenue Next Year
  • SBSI $5.41
  • WGSWW N/A
  • P/E Ratio
  • SBSI $10.43
  • WGSWW N/A
  • Revenue Growth
  • SBSI 5.30
  • WGSWW 50.79
  • 52 Week Low
  • SBSI $25.30
  • WGSWW $0.21
  • 52 Week High
  • SBSI $38.00
  • WGSWW $0.25
  • Technical
  • Relative Strength Index (RSI)
  • SBSI 39.12
  • WGSWW N/A
  • Support Level
  • SBSI $31.12
  • WGSWW N/A
  • Resistance Level
  • SBSI $32.32
  • WGSWW N/A
  • Average True Range (ATR)
  • SBSI 0.74
  • WGSWW 0.00
  • MACD
  • SBSI -0.09
  • WGSWW 0.00
  • Stochastic Oscillator
  • SBSI 7.63
  • WGSWW 0.00

About WGSWW GeneDx Holdings Corp.

GeneDx Holdings Corp delivers personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The company is uniquely positioned to accelerate the use of genomic and large-scale clinical information to enable precision medicine as the standard of care. GeneDx is at the forefront of transforming healthcare through its various exome and genome testing and interpretation, fueled by one of the world's substantial rare disease data sets.

Share on Social Networks: